Doheny Eye Institute, in partnership with Envision Consulting, is proud to announce the appointment of Alicia Cleaver as its new Chief Development Officer. Cleaver joins Doheny at a pivotal time as ...

Teeth are known by an array of names such as dens, pearly whites, grill, gnashers or ivories. Dr. Marielle Pariseau, founder ...

Amgen announces positive phase 3 results for subcutaneous Tepezza in adults living with moderate-to-severe active thyroid eye disease: Thousand Oaks, California Wednesday, April 8 ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical‑stage pharmaceutical company focused on modulating lipid‑signaling pathways to develop treatments for people living with cancer, pain, ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced the closing of its previously announced private placement of 3,188,407 shares of common stock (or pre-funded warrant in lieu thereof) and ...

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high.

She finally called her younger brother Jim, an eye surgeon, who advised her to see a neurologist right away. Alarmed, she ...

Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful Reduction ...

Over one billion people worldwide are over 60, and the population is projected to more than double by 2050. But as more ...